FDA Import Refusal SCS-9022142-7/11/1 — Ipsen BioPharm Ltd
The FDA refused shipment SCS-9022142-7/11/1 from Ipsen BioPharm Ltd (United Kingdom) on Jan 6, 2022. The refused product falls under Drugs and Biologics — BOTOX. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 6, 2022
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 65QAY02 BOTOX
- Charges
- 75